LCID
Lucid Group, Inc.
LCID has the edge over MPAA overall, supported by stronger fundamentals and stronger modeled upside.
MPAA
Motorcar Parts of America, Inc.
MPAA has lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MPAA Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Under pressure |
MPAA's revenue, profitability, cash flow and balance sheet are all currently under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
MPAA PE Valuation
MPAA has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MPAA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect MPAA's earnings to grow and its profitability to improve, with its revenue holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
MPAA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.61 | — |
| Q3 2026 | -$0.16 | -233% |
| Q2 2026 | -$0.24 | -400% |
| Q1 2026 | $0.62 | +$1.61 |
| Q4 2025 | $0.10 | +$1.00 |
| Q3 2025 | $0.12 | +$3.53 |
| Q2 2025 | $0.08 | +$3.44 |
| Q1 2025 | -$0.99 | +$1.52 |
| Q4 2024 | -$0.90 | +$1.59 |
MPAA has the edge over LCID on earnings, with more consistent year-over-year improvement.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over MPAA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
MPAA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $169.2M | -24% |
| Q2 2026 | $168M | -11% |
| Q1 2026 | $212.3M | +9.9% |
| Q4 2025 | $167.7M | -9.9% |
| Q3 2025 | $221.5M | +6.4% |
| Q2 2025 | $188.4M | +11% |
| Q1 2025 | $193.1M | +1.9% |
| Q4 2024 | $186.2M | +8.3% |
MPAA's revenue has slid since its 2025 peak: $169M last quarter, down 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.9% | -1.5 points |
| Q2 2026 | 2.1% | -8.6 points |
| Q1 2026 | 9.9% | +1.5 points |
| Q4 2025 | 5% | -4.5 points |
| Q3 2025 | 7.4% | +1.4 points |
| Q2 2025 | 11% | +14 points |
| Q1 2025 | 8.4% | +2 points |
| Q4 2024 | 9.4% | +3.9 points |
MPAA has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
MPAA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.8M | -123% |
| Q2 2026 | -$12.4M | -235% |
| Q1 2026 | -$6M | -195% |
| Q4 2025 | -$8.6M | -126% |
| Q3 2025 | $20.8M | -6.5% |
| Q2 2025 | $9.2M | +$30.6M |
| Q1 2025 | $6.2M | +$16.1M |
| Q4 2024 | $33.7M | -37% |
MPAA has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
MPAA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +19% | +3.6M shares |
| 1 year | +16% | +3.1M shares |
| 3 years | +15% | +2.9M shares |
| 5 years | +15% | +2.9M shares |
| Available history | +16% | +3.2M shares |
MPAA has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $1.9M |
| Q1 2026 | $3M |
| Q4 2025 | $5M |
| Q3 2025 | $1.4M |
| Q2 2025 | $2M |
| Q1 2025 | $2.7M |
| Q1 2023 | — |
MPAA spent $10M buying back its own shares over the past year.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MPAA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | 3.0x | Elevated |
| Q2 2024 | 3.5x | Elevated |
| Q1 2024 | 2.0x | Moderate |
| Q4 2023 | 1.5x | Healthy |
| Q3 2023 | 2.5x | Moderate |
| Q2 2023 | 3.1x | Elevated |
| Q1 2023 | 2.8x | Moderate |
| Q1 2020 | 3.9x | Elevated |
MPAA's net debt is about 3.0 years of its operating earnings (EBITDA), up from 2.5 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MPAA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.6 | Oversold |
| Stochastic | 11.6 | Oversold |
MPAA's weekly RSI is 27 (oversold) and its Stochastic is 12 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
MPAA PE vs Consumer Cyclical Sector
| Metric | MPAA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
MPAA has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
MPAA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.1 | 24% below |
| 20 week MA | $11.7 | 34% below |
| 50 week MA | $11.9 | 35% below |
| 100 week MA | $11.6 | 34% below |
| 200 week MA | $9.65 | 20% below |
MPAA is in a downtrend: it's below all five of its weekly moving averages, and 20% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
MPAA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.9 | $19.9 | -9.2% |
| 2021 | $19.9 | $16.7 | -16% |
| 2022 | $16.7 | $11.3 | -32% |
| 2023 | $11.3 | $9.34 | -17% |
| 2024 | $9.34 | $8.05 | -14% |
| 2025 | $8.05 | $12.5 | +55% |
| 2026 YTD | $12.5 | $7.71 | -38% |
MPAA has the edge over LCID on returns for 2026, with the stronger performance.